Glaceum is a company that develops drugs to treat metabolic diseases of aging by restoring mitochondrial function.

NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.

Meiji Co., Ltd. produces and sells milk, dairy, confectioneries, and food. Its products include cheese, ice cream, chocolate, infant formula, whey protein, beauty supplements, and yogurt. The company was founded on December 21, 1917 and is headquartered in Tokyo, Japan.

Taminco (NYSE: TAM) is a global specialty chemical company, with a clear focus on niche markets. They are the world's leading producer of alkylamines & derivatives and a major producer of formic acid & derivatives, supplying diversified, global end markets. Their products are used by customers in the manufacture of a diverse array of products for the agriculture, animal nutrition, water treatment, personal & home care and oil & gas end-markets. Their products provide these goods with a variety of ancillary characteristics required for optimal performance.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Xerox Corporation (/ˈzɪərɒks/; also known as Xerox) is an American global corporation that sells print and digital document products and services in more than 160 countries. Xerox is headquartered in Norwalk, Connecticut (having moved from Stamford, Connecticut in October 2007), though its largest population of employees is based around Rochester, New York, the area in which the company was founded. The company purchased Affiliated Computer Services for $6.4 billion in early 2010. As a large developed company, it is consistently placed in the list of Fortune 500 companies.

Part of Dechra Pharmaceuticals Plc, Dechra Ltd. is a British company located in Skipton that provides veterinary services. It was founded in 2002.\nThe company says this about itself: Dechra Pharmaceuticals Manufacturing (DPM) is one of the leaders in its field, providing a comprehensive range of pharmaceutical manufacturing and packing services from well-equipped facilities based in Skipton in the UK, Bladel in the Netherlands and Melbourne in Florida, USA. Our mission is to provide an excellent service supplying quality products to our customers worldwide.

Hefei Rice Biological Engineering Co., Ltd., established on 2008-02-03, The business scope includes yeast powder,Yeast extract(Extract powder)Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. Using its expertise and experience Biovitrum takes scientific innovation to patients with significant unmet medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within our prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company has revenues of approximately SEK 1.2 billion and around 400 employees. The company head office is located in Sweden. In 2009, Biovitrum merged with [Swedish Orphan](/organization/swedish-orphan), and the combined company has subsequently been rebranded as Swedish Orphan Biovitrum.

Qingdao Zhongren Pharmaceutical Co., Ltd., established on 2013-12-13, Business scope includes medical technology research and development and promotion services;Manufacture of daily disinfectant detergent(For mixing or dispensing only),Sales(None of the above products contain restricted or prohibited products such as hazardous chemicals,Freezing,refrigeration,Refrigeration,Hazardous Chemical Storage).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anhui Jinmu Feed Co., Ltd., established on 2009-06-11, Business scope includes licensed projects:feed production;Breeding livestock and poultry management;poultry farming;Livestock raising;aquaculture(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Feed Raw Material Sales;Animal Husbandry and Fishery Feed Sales;Grain Purchase;livestock sales;production of agricultural products,Sales,processing,transportation,Storage and other related services;Technology related to agricultural production and operation,information,Facilities construction and operation services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Agricultural Science Research and Experimental Development(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Sichuan Pharmaceutical, Inc., a subsidiary of Sichuan Huili Weike Investment Development Group Ltd., is a Chinese company. The firm operates as pharmaceutical company.

Guangxi Pingnan County Plain Agriculture and Animal Husbandry Co., Ltd., established on 2008-06-04, Business scope includes broiler farming,Sales;feed sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Jinan Weichuan Information Technology Co., Ltd., established on 2012-12-27, Business scope includes computer software and hardware technology development,technical consulting;Medical Technology Development;Chemical Products(Free of Hazardous Chemicals),General Machinery,Instrumentation,electronic product,Isales of medical devices;Network Engineering Design,construction;Intellectual Property Services;Business Management Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Tanghua Nano Technology Co., Ltd., established on 2014-04-14, The business scope includes nano-microcapsule materials,nano coating material,Research and development and technology transfer of environmentally friendly calendering embossing process;Testing services for new textile materials;Development and sales of functional textiles.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Fabric Textile Processing;Chemical product sales(No licensed chemical products);Biochemical product technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)